Muscle wasting: The gut microbiota as a new therapeutic target?

被引:145
|
作者
Bindels, Laure B. [1 ]
Delzenne, Nathalie M. [1 ]
机构
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium
关键词
Muscle wasting; Gut microbiota; Undernutrition; Cachexia; Probiotics; Prebiotics; SKELETAL-MUSCLE; KAPPA-B; OBESITY; MODULATION; ACTIVATION; MALNUTRITION; RESISTANCE; AUTOPHAGY; PROTECTS; CACHEXIA;
D O I
10.1016/j.biocel.2013.06.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Muscle wasting is characterized by a loss of muscle mass and strength, and occurs in several pathological conditions such as cancer, chronic heart failure, chronic infection and malnutrition. Muscle wasting can be caused by inflammation and inappropriate nutritional status. Interestingly, gut microbiota has recently been proposed as an environmental factor involved, among others, in energy sparing from the diet, and in the regulation of host immunity and metabolism. This review presents evidence supporting the existence of a gut microbiota-muscle axis and discusses the potential role and therapeutic interest of gut microbiota in muscle wasting, specifically in the context of cancer and malnutrition. This review also proposes possible molecular mechanisms underlying the gut microbiota-muscle axis. This article is part of a Directed Issue entitled: Molecular basis of muscle wasting. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2186 / 2190
页数:5
相关论文
共 50 条
  • [41] DYSBIOSIS IN GUT MICROBIOTA AS A THERAPEUTIC TARGET OF ALCOHOL-ASSOCIATED LIVER DISEASE
    Ikejima, K.
    Kitagawa, R.
    Kon, K.
    Uchiyama, A.
    Arai, K.
    Yamashina, S.
    Kuwahara-Arai, K.
    Kirikae, T.
    Ueno, T.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 45 : 27A - 27A
  • [42] Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation
    Hao, Yarong
    Hao, Zhiyuan
    Zeng, Xin
    Lin, Yong
    JOURNAL OF GASTROENTEROLOGY, 2024, 59 (09) : 788 - 797
  • [43] Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications
    Zhuang, Tongxi
    Li, Wei
    Yang, Li
    Wang, Zhengtao
    Ding, Lili
    Zhou, Mingmei
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [44] The gut microbiota as a target to control hyperuricemia pathogenesis: Potential mechanisms and therapeutic strategies
    Wang, Jing
    Chen, Yong
    Zhong, Hao
    Chen, Fang
    Regenstein, Joe
    Hu, Xiaosong
    Cai, Luyun
    Feng, Fengqin
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2022, 62 (14) : 3979 - 3989
  • [45] Gut Microbiota as Potential Therapeutic Target for the Treatment of Cow's Milk Allergy
    Canani, Roberto Berni
    Di Costanzo, Margherita
    NUTRIENTS, 2013, 5 (03): : 651 - 662
  • [46] The gut microbiota attenuates muscle wasting by regulating energy metabolism in chemotherapy-induced malnutrition rats
    Haitao Chen
    Chao Xu
    Fan Zhang
    Yu Liu
    Yong Guo
    Qinghua Yao
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 1049 - 1062
  • [47] A New Paradigm in the Relationship between Gut Microbiota and Breast Cancer: β-glucuronidase Enzyme Identified as Potential Therapeutic Target
    Fernandez-Murga, M. Leonor
    Gil-Ortiz, Fernando
    Serrano-Garcia, Lucia
    Llombart-Cussac, Antonio
    PATHOGENS, 2023, 12 (09):
  • [48] Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies
    Kang, Yongbo
    Cai, Yue
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (02) : 110 - 117
  • [49] DEVELOPMENT OF THERAPEUTIC STRATEGIES FOR MUSCLE WASTING
    Krishnan, G.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : 561 - 561
  • [50] Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis
    Kujawa, Dorota
    Laczmanski, Lukasz
    Budrewicz, Slawomir
    Pokryszko-Dragan, Anna
    Podbielska, Maria
    GUT MICROBES, 2023, 15 (02)